Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Daily News

Stent Grafts Better Than Angioplasty for Failing Dialysis-Access Grafts

Jason Kahn

April 19, 2013

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Daily News

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

March 06, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

Presentation TCT 2012

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Presenter: Weon Kim, Won-Yu Kang, Jong-Shin Woo

January 03, 2012

News Daily News

Early Morning Circadian Rhythms Linked to Stent Thrombosis

February 21, 2011

News Daily News

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Caitlin E. Cox

January 06, 2011

Advertisement

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Stent Grafts Better Than Angioplasty for Failing Dialysis-Access Grafts

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Early Morning Circadian Rhythms Linked to Stent Thrombosis

Cell Therapy Shows Promise for Limb Ischemia Due to PAD, Buerger’s Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content